Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting recurrent Clostridioides difficile infection by assessing antimicrobial treatment based on days of antibiotic spectrum coverage and ATLAS scores.
Nagaoka H, Morita Y, Ohya T, Takahashi K, Sato J, Miyata M, Iwashita S, Arai Y, Kiuchi S, Ozone H, Matsumoto T. Nagaoka H, et al. Among authors: matsumoto t. J Infect Chemother. 2024 Dec 27;31(3):102603. doi: 10.1016/j.jiac.2024.102603. Online ahead of print. J Infect Chemother. 2024. PMID: 39734001
Building vancomycin population pharmacokinetic model for Japanese low birth weight infants in comparing it with previously reported pediatric population pharmacokinetic models.
Masuda KOJI, Ikeda KENJI, Endo AIJU, Ishikawa TAKAHIRO, Matsumoto TETSUYA. Masuda KOJI, et al. Among authors: matsumoto tetsuya. J Infect Chemother. 2024 Dec 11:S1341-321X(24)00327-1. doi: 10.1016/j.jiac.2024.12.009. Online ahead of print. J Infect Chemother. 2024. PMID: 39672323
Third nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2020 and 2021: Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.
Wada K, Tsuboi I, Takahashi S, Yasuda M, Miyazaki J, Kobayashi K, Matsumoto M, Hayami H, Yamamoto S, Kiyota H, Sato J, Matsumoto T, Hasegawa N, Kobayashi I, Masumori N, Kimura T, Yamada H, Matsumoto K, Ishikawa K, Fujimoto K, Shigemura K, Sadahira T, Ito K, Yokoyama T, Izumitani M, Sumii T, Hosobe T, Hikosaka K, Kawahara M, Sato T, Ito S, Masue N, Sakurai T, Kokura K, Kadena H, Morikawa T, Minamidate Y, Yoh M, Hashimoto J, Maruyama T, Yoshioka M, Takashima K, Kawai S, Nishi S, Matsumoto T, Hirayama H, Okusa H, Uno S, Inoue Y, Kurimura Y, Shirane T, Takaoka E, Tojo T, Arakawa S, Hamasuna R, Tomioka A, Iihara K, Ishitoya S, Maeda H, Terado M. Wada K, et al. Among authors: matsumoto k, matsumoto m, matsumoto t. J Infect Chemother. 2024 Apr;30(4):277-285. doi: 10.1016/j.jiac.2024.01.011. Epub 2024 Jan 17. J Infect Chemother. 2024. PMID: 38242285
Fourth national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from patients with complicated urinary tract infections.
Kobayashi K, Takahashi S, Yasuda M, Miyazaki J, Wada K, Matsumoto M, Hayami H, Yamamoto S, Kiyota H, Sato J, Matsumoto T, Hasegawa N, Kobayashi I, Masumori N, Kimura T, Yamada H, Nakagawa T, Kaneko T, Matsumoto K, Fujimura T, Kamei J, Ishikawa K, Fujimoto K, Nakai Y, Shigemura K, Sadahira T, Hinata N, Kitano H, Yamashita M, Yasufuku T, Komeda H, Hiyama Y, Takahashi Y, Kanamaru S, Murakami M, Arakawa S, Yamada D, Mita K, Hamasuna R, Tanaka K, Matsukawa M, Takaoka E, Shigeta M, Takenaka T, Nishino M, Ishitoya S, Hayakawa S, Okumura K, Ueda M. Kobayashi K, et al. Among authors: matsumoto k, matsumoto m, matsumoto t. J Infect Chemother. 2024 Jul;30(7):579-589. doi: 10.1016/j.jiac.2024.03.024. Epub 2024 Apr 6. J Infect Chemother. 2024. PMID: 38588797
Factors associated with the change of antimicrobial prescription before and after the national action plan on antimicrobial resistance: Additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases.
Morioka S, Tsuzuki S, Gu Y, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N. Morioka S, et al. Among authors: matsumoto t. J Infect Chemother. 2025 Feb;31(2):102532. doi: 10.1016/j.jiac.2024.09.021. Epub 2024 Oct 2. J Infect Chemother. 2025. PMID: 39366453 Free article.
Chapter 2-12-7. Anaerobic infections (individual fields): antibiotic-associated diarrhea and enterocolitis.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:137-9. doi: 10.1007/s10156-010-0160-7. J Infect Chemother. 2011. PMID: 21728113 Free article. No abstract available.
Chapter 3-5. Appendix: Pharmacokinetics of antimicrobial agents indicated for anaerobic infections.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:176-9. doi: 10.1007/s10156-010-0165-2. J Infect Chemother. 2011. PMID: 21728118 Free article. No abstract available.
Chapter 3-4. Appendix: Antimicrobial agents indicated for anaerobes (listed by dosing route and chemical class).
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:165-75. doi: 10.1007/s10156-010-0164-3. J Infect Chemother. 2011. PMID: 21728117 Free article. No abstract available.
Chapter 2-5-1. Anaerobic infections (individual fields): prevention and treatment of postoperative infections.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:62-6. doi: 10.1007/s10156-010-0141-x. J Infect Chemother. 2011. PMID: 21728094 Free article. No abstract available.
10,264 results
You have reached the last available page of results. Please see the User Guide for more information.